Lumixyl: the New Hydroquinone?

39490-lo-bottle_4

Almost everyone worries about those dreaded dark spots in their lifetime – that is, sun spots, age spots, liver spots.  (haha ;-))  All joking aside, hyperpigmentation and melasma often require serious treatments.  And since 1982, the gold standard in dermatologists’ offices has been hydroquinone, a potent tyrosinase inhibitor that may also work by inducing cytotoxicity in melanocytes.  However, even though hydroquinone has been found in numerous studies to be safe (as mentioned in a 2006 review in the Journal of the American Academy of Dermatology), the ingredient has still been banned in some countries, including France and South Africa, for concerns about increased cancer risk and ochronosis (darkening of the skin) with its use.

With that concern in mind, Stanford University researchers recently developed LumixylTM, a complex of oligopeptides (0.1% w/w) that has been found to significantly inhibit tyrosinase, the rate-limiting enzyme in melanin production.  According to a 2009 study in The Journal of Drugs in Dermatology, LumixylTM also improved melasma and overall facial aesthetics in five female participants – a significant finding in such a well-controlled study, though the sample size was small.  Still, as researchers report, LumixylTM seems to hold great promise for treating hyperpigmentation and melasma.  As I learned in a recent opportunity to interview LumixylTM scientists, the great promise of LumixylTM is the product’s ability to “deliver efficacy similar to hydroquinone, without the potential toxicity”.

Clearly, more research needs to be done before LumixylTM is granted the gold -standard status of hydroquinone for treating hyperpigmentation.  Still, the product appears to hold great promise, and it will be exciting to follow it as more research becomes available.  It is currently being sold exclusively through participating physicians’ offices for $120.00 for a 1 ounce pump.

A special thanks to Lumixyl researchers and Melissa Kelz, PR for providing me with the informative interview.

Related Posts

  • Dear Nicki, Which is better:  kojic acid or hydroquinone? -M Dear M, In a word: hydroquinone. A study in the Journal of Cosmetic Dermatology reported kojic acid alone is less efficacious than 2% hydroquinone in treating hyperpigmentation (i.e., sun spots, uneven skin pigmentation, and the like). Kojic acid has also been found to be associated with contact…
  • From the FutureDerm.com Facebook page: Hi Nicki, I was wondering if people who suffer from hyperpigmentation can use bronzers/self-tanners, since [I think] they stimulate melanin production, which we try to stop with serums and creams to fight hyperpigmentation? -Càtia Dear Càtia, The short answer is that you can use bronzers without a problem with age…
  • "Out, damned spot!" is often an exclamatory phase spoken in laundry detergent ads, but it should be echoed in beauty product ads just as often. In the U.S., the best-selling beauty products in skin care are sun protection, anti-aging, acne, and hyperpigmentation treatments (in descending order). But in the global market, hyperpigmentation treatments are number…

by Nicki Zevola

7 thoughts on “Lumixyl: the New Hydroquinone?

  1. stacey says:

    I did too, same thing happen to me. I started using a vitamin c+e+ferulic serum, and it totally reversed my face with alpha arbutin. you can barely tell my hyperpigmentation is there anymore.

  2. Pingback: Product Review: Kiehl’s Photo-Age High-Potency Spot Treatment « FutureDerm.com

  3. Pingback: FutureDerm.com » Estée Lauder Idealist Even Skintone Illuminator Product Review

  4. Pingback: Dr. Jart+ Premium Beauty Balm SPF 45 PA+++ Review: No Need to Fly to Korea Anymore! | FutureDerm.com

  5. Pingback: Daily Question: What are the Best Brightening Ingredients in Skin Care? | FutureDerm.com

  6. Pingback: 9 Things You Must Know About Skin Bleaching -- Starting With The Knowledge 1 in 3 Women Worldwide Do or Have Done It | FutureDerm - Skin Care - Retinol - Beauty Blog

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>